Clinical Operations

Learn what goes into an effective site feasibility questionnaire and how an experienced consultant can help inform your strategy.

Thorough planning is especially critical for Phase 1 trials, as even minor delays can cause major downstream effects.

What early tactics should you consider to improve your chances of a successful rare disease trial?

What should sponsors take into consideration when planning a schizophrenia clinical trial & download PharPoint’s experience overview.

Asking the right questions is key to determining how successful sites will be in ensuring the overall success of your Phase 1 study.

In this article , we discuss how CRAs review adverse events, including the role of a CRA and what documentation is needed.

What makes PharPoint’s clinical operations team unique? PharPoint clinical research associate (CRA) Sophie chats with us in this short clip.

PharPoint’s clinical team members have extensive experience within CHF trials. Our team has found that one of the biggest challenges these studies encounter is the issue of non-compliance.

We discuss six techniques from PharPoint’s enrollment toolkit, deployed to help keep our clients study enrollment on track.

A strategic clinical development plan (CDP) can help Sponsors optimize their new drug programs. What should you include in your CDP?